XtalPi Holdings Limited (HKG:2228)

Market Cap	19.17B
Revenue (ttm)	283.53M
Net Income (ttm)	-1.61B
Shares Out	4.02B
EPS (ttm)	-0.84
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	10,720,000
Average Volume	51,686,517
Open	4.710
Previous Close	4.770
Day's Range	4.670 - 4.800
52-Week Range	3.050 - 16.200
Beta	n/a
RSI	43.09
Earnings Date	May 28, 2025

About XtalPi Holdings

XtalPi Holdings Limited, an investment holding company, engages in the provision of robotics and drug discovery solutions in Mainland China, the United States, and internationally. The company offers XMolGen, an AI small molecule drug discovery smart computation platform; XtalFold, an antibody-antigen complex structure prediction platform which predicts the antibody-antigen complex structure and identifies key interaction sites; and Xtalgazer, a new generation of drug crystallization research and development platform which predict the physicoch...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2015
• Employees: 809
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2228

Financial Performance

In 2024, XtalPi Holdings's revenue was 266.43 million, an increase of 52.75% compared to the previous year's 174.42 million. Losses were -1.52 billion, -20.78% less than in 2023.

Financial numbers in CNY